A Network Analysis of Epigenetic and Transcriptional Regulation in a Neurodevelopmental Rat Model of Schizophrenia With Implications for Translational Research

被引:24
作者
Du, Yang [1 ]
Li, Xue-Song [2 ]
Chen, Lei [1 ]
Chen, Guang-Yang [2 ]
Cheng, Yong [1 ,3 ]
机构
[1] Minzu Univ China, Coll Life & Environm Sci, Ctr Translat Neurosci, Key Lab Ethnomed,Minist Educ, 27 Zhongguancun South St, Beijing 100081, Peoples R China
[2] Third Peoples Hosp Foshan, Inst Neuropsychiat Dis, Foshan, Guangdong, Peoples R China
[3] Hunan Prov Maternal & Child Hlth Care Hosp, NHC Key Lab Birth Defects Res Prevent & Treatment, Changsha, Hunan, Peoples R China
基金
北京市自然科学基金; 中国国家自然科学基金;
关键词
methylazoxymethanol acetate; mRNA; miRNA; prefrontal cortex; hippocampus; DEVELOPMENTAL DISRUPTION MODEL; PLACEBO-CONTROLLED TRIAL; METHYLAZOXYMETHANOL ACETATE; DOUBLE-BLIND; INFLAMMATION; METAANALYSIS; DOPAMINE; BRAIN; ONSET;
D O I
10.1093/schbul/sbz114
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Prenatal administration of mitotoxin methylazoxymethanol acetate (MAM) in rats produces behavioral, pharmacological, and anatomical abnormalities once offspring reach adulthood, thus establishing a widely used neurodevelopmental model of schizophrenia. However, the molecular aspects underlying this disease model are not well understood. Therefore, this study examines epigenetic and transcriptional dysregulation in the prefrontal cortex and hippocampus of MAM rats as these are brain regions closely associated with schizophrenia pathogenesis. Upon sequencing messenger and microRNA (mRNA and miRNA, respectively), differential expression was revealed in the prefrontal cortex and hippocampus between MAM- and saline-treated rats; sequencing data were validated by qualitative real-time polymerase chain reaction. Bioinformatic analyses demonstrated that the differentially expressed (DE) genes were strongly enriched in interactive pathways related to schizophrenia, including chemical synaptic transmission, cognition, and inflammatory responses; also, the potential target genes of the DE miRNAs were enriched in pathways related to synapses and inflammation. The blood of schizophrenia patients and healthy controls was further analyzed for several top DE mRNAs: DOPA decarboxylase, ret proto-oncogene, Fc receptor-like 2, interferon lambda receptor 1, and myxovirus (influenza virus) resistance 2. The results demonstrated that the expression of these genes was dysregulated in patients with schizophrenia; combining these mRNAs sufficiently differentiated schizophrenia patients from controls. Taken together, this study suggests that the MAM model has the potential to reproduce hippocampus and prefrontal cortex abnormalities, relevant to schizophrenia, at the epigenetic and transcriptional levels. These data also provide novel targets for schizophrenia diagnoses and treatments.
引用
收藏
页码:612 / 622
页数:11
相关论文
共 30 条
  • [1] Dopamine, the antipsychotic molecule: A perspective on mechanisms underlying antipsychotic response variability
    Amato, Davide
    Vernon, Anthony C.
    Papaleo, Francesco
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2018, 85 : 146 - 159
  • [2] Hippocampal-prefrontal connectivity as a translational phenotype for schizophrenia
    Baehner, Florian
    Meyer-Lindenberg, Andreas
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 (02) : 93 - 106
  • [3] Neuroinflammation and Schizophrenia
    Buckley, Peter F.
    [J]. CURRENT PSYCHIATRY REPORTS, 2019, 21 (08)
  • [4] Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment
    Chaudhry, Imran B.
    Hallak, Jaime
    Husain, Nusrat
    Minhas, Fareed
    Stirling, John
    Richardson, Paul
    Dursun, Serdar
    Dunn, Graham
    Deakin, Bill
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2012, 26 (09) : 1185 - 1193
  • [5] N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis
    Conus, Philippe
    Seidman, Larry J.
    Fournier, Margot
    Xin, Lijing
    Cleusix, Martine
    Baumann, Philipp S.
    Ferrari, Carina
    Cousins, Ann
    Alameda, Luis
    Gholam-Rezaee, Mehdi
    Golay, Philippe
    Jenni, Raoul
    Woo, T. -U. Wilson
    Keshavan, Matcheri S.
    Eap, Chin B.
    Wojcik, Joanne
    Cuenod, Michel
    Buclin, Thierry
    Gruetter, Rolf
    Do, Kim Q.
    [J]. SCHIZOPHRENIA BULLETIN, 2018, 44 (02) : 317 - 327
  • [6] Genome-Wide, Integrative Analysis Implicates Exosome-Derived MicroRNA Dysregulation in Schizophrenia
    Du, Yang
    Yu, Yun
    Hu, Yang
    Li, Xiao-Wan
    Wei, Ze-Xu
    Pan, Rui-Yuan
    Li, Xue-Song
    Zheng, Guang-En
    Qin, Xiao-Yan
    Liu, Qing-Shan
    Cheng, Yong
    [J]. SCHIZOPHRENIA BULLETIN, 2019, 45 (06) : 1257 - 1266
  • [7] Peripubertal Diazepam Administration Prevents the Emergence of Dopamine System Hyperresponsivity in the MAM Developmental Disruption Model of Schizophrenia
    Du, Yijuan
    Grace, Anthony A.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2013, 38 (10) : 1881 - 1888
  • [8] Age of Onset of Schizophrenia: Perspectives From Structural Neuroimaging Studies
    Gogtay, Nitin
    Vyas, Nora S.
    Testa, Renee
    Wood, Stephen J.
    Pantelis, Christos
    [J]. SCHIZOPHRENIA BULLETIN, 2011, 37 (03) : 504 - 513
  • [9] Alterations in medial prefrontal cortical activity and plasticity in rats with disruption of cortical development
    Goto, Yukiori
    Grace, Anthony A.
    [J]. BIOLOGICAL PSYCHIATRY, 2006, 60 (11) : 1259 - 1267
  • [10] The Methylazoxymethanol Acetate (MAM-E17) Rat Model: Molecular and Functional Effects in the Hippocampus
    Hradetzky, Eva
    Sanderson, Thomas M.
    Tsang, Tsz M.
    Sherwood, John L.
    Fitzjohn, Stephen M.
    Lakics, Viktor
    Malik, Nadia
    Schoeffmann, Stephanie
    O'Neill, Michael J.
    Cheng, Tammy M. K.
    Harris, Laura W.
    Rahmoune, Hassan
    Guest, Paul C.
    Sher, Emanuele
    Collingridge, Graham L.
    Holmes, Elaine
    Tricklebank, Mark D.
    Bahn, Sabine
    [J]. NEUROPSYCHOPHARMACOLOGY, 2012, 37 (02) : 364 - 377